Bacterial Infection Due to Streptococcus, Group B

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Bacterial Infection Due to Streptococcus, Group B trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07562061

mulTiplex Immunoassay qualiTy assuRance Panel

Collection of serum from women not living with HIV, who received the GBS6 vaccine in the "a placebo-controlled clinical trial investigating the safety and immun…

Uganda50 participantsStarted 2026-03-27

Treatment: Collection of 50mls of blood

All recent trials (29 shown)

Active — Not RecruitingPhase 2/3

NCT06592586

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

The main objective of the study is to evaluate the persistence of the immunoglobulin G (IgG) antibody responses, specific to Alpha-like protein CN (AlpCN), Ribo…

Denmark, South Africa338 participantsStarted 2025-03-07

Treatment: GBS-NN/NN2 vaccine

Active — Not RecruitingPhase 1/2

NCT06611371

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women…

To assess the safety and tolerability of IVT GBS-06 vaccine administered as a single-dose regimen, at three dosage levels in healthy, non-pregnant, adult women…

United States, South Africa600 participantsStarted 2024-11-12

Treatment: IVT GBS-06, Placebo

Bacterial Infection Due to Streptococcus, Group B

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

mulTiplex Immunoassay qualiTy assuRance Panel

All recent trials (29 shown)

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

mulTiplex Immunoassay qualiTy assuRance Panel

All recent trials (29 shown)

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women…

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Group B Streptococcus Response After Probiotic Exposure

Serosurveillance Study of Maternally Derived Anti-GBS Antibody

Group B Streptococcus Infection and PROM Incidince

Colonization with Group B Streptococcus During Pregnancy

GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given…

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pre…

Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease

Serocorrelate of Protection Against GBS (PREPARE WP3)

Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV

Invasive Group B Streptococcus Disease Burden and Its Antimicrobial Resistance in Malaysia Among Non-pregnant Adults.

MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDY

Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women

Time Frame for GBS Screening